HYDROVAL OINTMENT 0.2% 0.2 %
HYDROCORTISONE VALERATE : 0.2 % · DIN 02242985 · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
Health Canada status: MARKETED
What is HYDROVAL OINTMENT 0.2%?
HYDROVAL OINTMENT 0.2% 0.2 % contains HYDROCORTISONE VALERATE : 0.2 %. It is listed in the Health Canada Drug Product Database under DIN 02242985, held by TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as marketed, status dated 06-Apr-2004. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is HYDROVAL OINTMENT 0.2% used for?
Topical therapy of acute and chronic corticosteroid responsive dermatoses where anti-inflammatory, anti-allergenic, and antipruritic activity is required.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02242985 |
|---|---|
| Brand name | HYDROVAL OINTMENT 0.2% |
| Generic / active ingredient | HYDROCORTISONE VALERATE : 0.2 % |
| Manufacturer | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| Strength | 0.2 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AA02 HYDROCORTISONE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Apr-2004 |
How is it administered?
Apply a small amount to affected areas 2 to 3 times daily as needed. Rub in gently and completely. Discontinue as soon as lesions heal. Do not use under occlusive dressings unless directed.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15-25°C).
How is it supplied?
Cream: tubes of 15, 45, and 60 g. Ointment: tubes of 15 and 60 g.
Contraindications
Hypersensitivity to components; bacterial/fungal skin infections, tuberculosis of skin, syphilitic skin infections, chicken pox, viral diseases of the skin. Not for ophthalmic use.
Warnings and precautions
Systemic absorption can cause HPA axis suppression, Cushing’s syndrome, and adrenal suppression, especially with occlusive dressings, extensive areas, or use on the face/axillae.
What can be used instead?
Other Canadian products sharing ATC code D07AA02 HYDROCORTISONE. 3 of 34 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HYDROVAL CREAM 0.2% | 0.2 % | CREAM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | MARKETED | DIN 02242984 |
| SANDOZ HYDROCORTISONE | 2.5 % | CREAM | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02469421 |
| ALOCORT 1% - CRM | 1 % | CREAM | UCB INC | CANCELLED POST MARKET | DIN 02176408 |
| AQUACORT LOTION 2.5% | 2.5 % | LOTION | MERIT INDUSTRIES INC. | CANCELLED POST MARKET | DIN 01940120 |
| AVEENO HYDROCORTISONE ANTI-ITCH CREAM | 0.5 % | CREAM | JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02244959 |
| BARRIERE HC 1% | 1 % | JELLY ; CREAM | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00465070 |
| CORTACET CRM 0.5% | 0.5 % | CREAM | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932381 |
| CORTATE CRM 1% | 10 MG | CREAM | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00502200 |
| CORTATE ONT 1% | 10 MG | OINTMENT | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00502197 |
| CORTICREME 0.1% | 1 MG | CREAM | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 00477680 |
Who else supplies HYDROCORTISONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROCORTISONE appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.